Journal: Frontiers in Pharmacology
Article Title: Searching for Drug Synergy Against Cancer Through Polyamine Metabolism Impairment: Insight Into the Metabolic Effect of Indomethacin on Lung Cancer Cells
doi: 10.3389/fphar.2019.01670
Figure Lengend Snippet: Effect of indomethacin on the expression of SAT1 and levels of spermidine/spermine-N 1 -acetyltransferase (SSAT) in non-small cell lung cancer (NSCLC) cells. A549 and H1299 cells were exposed to indomethacin 0.5 and 1 mM for 24 h. The messenger RNA (mRNA) levels of SAT1 and protein levels of SSAT were evaluated using quantitative PCR (qPCR) and western blotting, respectively. (A) The mRNA levels of SAT1 in A549 cells. (B) Representative blot of the SSAT protein levels in A549 cells exposed to indomethacin. (C) Quantitation of the SSAT levels in A549 cells exposed to indomethacin. (D) The mRNA levels of SAT1 in H1299 cells. (E) Representative blot of the SSAT levels in H1299 cells exposed to indomethacin. (F) Quantitation of the SSAT levels in H1299 cells exposed to indomethacin. * p < 0.05; ** p < 0.01, *** p < 0.0001 and ns, no significant compared with untreated control, calculated using one-way ANOVA and Dunnett’s post-test. Data summarize the results of three independent experiments.
Article Snippet: The RNA obtained was treated with the Turbo DNA-free ® deoxyribonuclease (DNAse) kit (Thermo Fisher Scientific, Vilnius, Lithuania), followed by complementary DNA (cDNA) synthesis using the AffinityScript™ Quantitative PCR (qPCR) cDNA synthesis kit (Agilent Technologies, Cedar Creek, TX, USA).
Techniques: Expressing, Real-time Polymerase Chain Reaction, Western Blot, Quantitation Assay